Alligator Bioscience Investor Relations Material
Alligator Bioscience AB, is a research-based biotechnology company, which specialises in the development of novel antibody-based drugs for cancer treatment with a foundation in Sweden. The Company's pipeline includes anti-carcinoembryonic antigen monoclonal antibody, called GA101, which has demonstrated significant efficacy and tolerability in several clinical trials. The company is based in Lund, Sweden
Upcoming events for
Q2 20222022-07-12
Latest company events
Ticker symbol
ATROX
Country
Sweden
About the company
Investor Relations Page
Dig deeper into the Alligator Bioscience fundamentals on Quartr.
- Skip straight to the Q&A session
- Receive notifications about new events
- Connect the financial calender on your phone
- Figure out why the stock is up or down
- Read the transcripts or scroll the deck
- Access earnings or press releases
